REG - Morgan Sindall Grp - Director/PDMR Shareholding

Morgan SindallAnnouncement

07/03/2025 13:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250307:nRSG8689Za&default-theme=true

RNS Number : 8689Z  Morgan Sindall Group PLC  07 March 2025

Morgan Sindall Group plc (the "Company")

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

The following notification is intended to satisfy the Company's obligations
under Article 19.3 of EU Regulation No 596/2014 (the Market Abuse Regulation).

 

 1.  Details of Restricted Person/person closely associated with them ("PCA")
 a)  Name                                                            John Morgan (Chief Executive)
 2.  Reason for the notification
 a)  Position/status                                                 Chief Executive Officer
 b)  Initial notification/amendment                                  Initial notification
 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                            Morgan Sindall Group plc
 b)  LEI                                                             2138008339ULDGZRB345
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument     Ordinary shares of 5 pence each

     Identification code

                                                                     ISIN: GB0008085614
 b)  Nature of the transaction                                       Vesting of nil cost share options granted on 7 March 2022, under the Company's
                                                                     Deferred Bonus Plan, adopted by the Company on 28 November 2017.  Upon
                                                                     vesting of the deferred bonus plan award on 7 March 2025, each nil cost option
                                                                     granted carried a right to receive an amount linked to dividends paid.  The
                                                                     dividend equivalent has been settled in Ordinary shares of the Company and has
                                                                     been added to the original award of nil cost options.

                                                                     The options and dividend equivalent shares are exercisable until the tenth
                                                                     anniversary of the grant date.
 c)  Price(s) and volume(s)                                          Name         Price(s)  Volume(s)
                                                                                 Dividend equivalent shares awarded
                                                                     John Morgan  N/a       912
 d)  Aggregated information                                          As above

     -     Aggregated volume

     -     Price
 e)  Date of the transaction                                         7 March 2025
 f)  Place of the transaction                                        Outside a trading venue

d)

Aggregated information

-     Aggregated volume

-     Price

As above

 

e)

Date of the transaction

7 March 2025

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFFVVRIDIIE